Find Meth & Stimulant
Addiction Treatment Centers

Understanding Meth Addiction

Methamphetamine is a powerful stimulant that floods the brain with dopamine — up to three times more than cocaine — producing intense euphoria, increased energy, and heightened alertness. But repeated use depletes the brain's dopamine system, creating a cycle of escalating use as people chase diminishing highs. The neurological damage meth causes can take months to years to heal, making early and intensive treatment critical.

Methamphetamine use disorder has been a growing public health crisis, with use rates increasing sharply in recent years alongside the wider drug epidemic. Unlike opioid addiction, there is currently no FDA-approved medication specifically for meth addiction — but this does not mean treatment is ineffective. Behavioral therapies have strong evidence for meth addiction, and recovery is achievable with the right approach and adequate treatment duration.

Crystal Meth vs. Prescription Stimulants

Methamphetamine addiction — often called crystal meth addiction — involves illicitly manufactured stimulants. A separate but related issue is addiction to prescription stimulants such as Adderall (amphetamine), Ritalin (methylphenidate), and Vyvanse, which are widely prescribed for ADHD and are sometimes misused. Both are treated in the same category of stimulant use disorder, though prescription stimulant addiction is often less severe and may respond better to outpatient treatment alone.

What Happens During Meth Withdrawal?

Meth withdrawal is not typically medically life-threatening, but it can be intense and prolonged. The "crash" after stopping meth involves extreme fatigue, sleeping for 12 to 20 hours at a time, profound depression, intense drug cravings, anxiety, irritability, and cognitive difficulties including problems with memory and concentration. Depression can be severe enough to cause suicidal thoughts and warrants clinical monitoring.

Symptoms peak in the first 1 to 3 days and gradually improve over 1 to 2 weeks, though protracted withdrawal symptoms — including anhedonia (inability to feel pleasure) and cravings — can persist for weeks to months as the brain's dopamine system slowly recovers. This protracted withdrawal is one reason longer treatment episodes (90+ days) are more effective for meth addiction.

Behavioral Treatment: What Works for Meth

Because no medication is FDA-approved for meth use disorder, behavioral therapy is the cornerstone of treatment. The two evidence-based approaches with the strongest research support are:

Contingency Management (CM): Patients earn rewards — typically vouchers or prizes — for each negative drug test. CM has the strongest evidence base of any psychosocial intervention for stimulant use disorder. Research consistently shows it reduces meth use, improves treatment retention, and extends the period of abstinence. Many insurance plans and state Medicaid programs now cover CM.

Cognitive Behavioral Therapy (CBT): Helps patients identify the thoughts, emotions, and situations that trigger meth use, develop coping strategies, and build skills for resisting cravings. The Matrix Model — a structured 16-week outpatient program combining CBT, relapse prevention, family education, and 12-step participation — was specifically developed for stimulant use disorder and has strong research support.

Why Residential Treatment Is Recommended

For moderate to severe meth addiction, residential treatment is strongly recommended. The protracted withdrawal period, combined with strong drug cravings and often chaotic life circumstances associated with heavy meth use, makes outpatient-only treatment difficult to sustain. Residential programs provide the structure, 24/7 support, and complete removal from drug-using environments that create the best conditions for the brain to begin healing.

Clinical guidelines recommend at least 90 days of residential treatment for meth addiction. Programs shorter than 90 days have significantly higher relapse rates. After residential treatment, step-down to IOP with continued CM and CBT maintains gains.